• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤利什曼病患者愈合及未愈合皮损的免疫反应

Immune response in cutaneous leishmaniasis patients with healing . non-healing lesions.

作者信息

Miramin-Mohammadi Akram, Javadi Amir, Eskandari Seyed Ebrahim, Mortazavi Hossein, Rostami Mahmoud Nateghi, Khamesipour Ali

机构信息

Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.

Department of Social Medicines, Qazvin University of Medical Sciences, Qazvin, Iran.

出版信息

Iran J Microbiol. 2020 Jun;12(3):249-255.

PMID:32685122
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7340611/
Abstract

BACKGROUND AND OBJECTIVES

The outcome of infection mainly depends upon the species which causes the disease and the generation of the type of host immune response, the healing process and protection in leishmaniasis depends upon induction of Th1 response. In this study, the Th1/Th2 cytokine profile in cutaneous leishmaniasis (CL) is evaluated.

MATERIALS AND METHODS

This study was carried out in leishmaniasis clinic of CRTSDL, TUMS, during March 2018 to March 2019. Peripheral blood mononuclear cells (PBMC) of volunteers with active healing and non-healing lesion (s) of cutaneous leishmaniasis (CL), volunteers with and without history of CL were cultured and stimulated with Soluble antigen (SLA). The supernatants were collected and the levels of IFN-γ, IL-5 and IL-10 were titrated using ELISA method.

RESULTS

The results showed a significantly higher levels of IFN-γ in volunteers with active CL healing form (<0.005), history of CL (<0.005) than healthy volunteers. A significantly (<0.005) higher level of IFN-γ was seen in volunteers with active healing form of lesion than non-healing form. There was a significantly (<0.005) higher level of IL-10 in volunteers with a history of non-healing form and active non-healing form of CL. There was no significant difference in IL-5 production in PBMC of different groups.

CONCLUSION

IFN-γ production starts at early stage of cutaneous leishmaniasis and enhance during course of lesion healing, IFN-γ level is significantly higher in all patients compared to healthy volunteers, IFN-γ is significantly higher in patients with healing form than non-healing form of lesion.

摘要

背景与目的

感染的结果主要取决于引起疾病的物种以及宿主免疫反应类型的产生,利什曼病的愈合过程和保护取决于Th1反应的诱导。在本研究中,评估了皮肤利什曼病(CL)中的Th1/Th2细胞因子谱。

材料与方法

本研究于2018年3月至2019年3月在德黑兰医科大学CRTSDL的利什曼病诊所进行。对患有皮肤利什曼病(CL)活动性愈合和未愈合病变的志愿者、有和没有CL病史的志愿者的外周血单个核细胞(PBMC)进行培养,并用可溶性抗原(SLA)刺激。收集上清液,采用酶联免疫吸附测定(ELISA)法测定IFN-γ、IL-5和IL-10的水平。

结果

结果显示,活动性CL愈合型志愿者(<0.005)、有CL病史的志愿者(<0.005)的IFN-γ水平显著高于健康志愿者。病变活动性愈合型志愿者的IFN-γ水平显著高于未愈合型(<0.005)。有CL未愈合型病史和活动性未愈合型的志愿者中IL-10水平显著更高(<0.005)。不同组PBMC中IL-5的产生无显著差异。

结论

IFN-γ在皮肤利什曼病早期产生,并在病变愈合过程中升高,所有患者的IFN-γ水平均显著高于健康志愿者,愈合型病变患者的IFN-γ水平显著高于未愈合型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9274/7340611/31622c187adb/IJM-12-249-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9274/7340611/31622c187adb/IJM-12-249-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9274/7340611/31622c187adb/IJM-12-249-g001.jpg

相似文献

1
Immune response in cutaneous leishmaniasis patients with healing . non-healing lesions.皮肤利什曼病患者愈合及未愈合皮损的免疫反应
Iran J Microbiol. 2020 Jun;12(3):249-255.
2
Comparison of cytokine profile of IFN-γ, IL-5 and IL-10 in cutaneous leishmaniasis using PBMC whole blood.使用外周血单个核细胞全血比较皮肤利什曼病中IFN-γ、IL-5和IL-10的细胞因子谱。
Iran J Microbiol. 2019 Oct;11(5):431-439.
3
Immune Responses in Cutaneous Leishmaniasis: Thelper1/Thelper2 Cytokine Profiles Using Live Versus Killed .皮肤利什曼病中的免疫反应:使用活疫苗与灭活疫苗的辅助性T细胞1/辅助性T细胞2细胞因子谱
J Arthropod Borne Dis. 2021 Mar 31;15(1):126-135. doi: 10.18502/jad.v15i1.6491. eCollection 2021 Mar.
4
A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.一种重组利什曼原虫抗原,可刺激人外周血单核细胞表达Th1型细胞因子谱并产生白细胞介素12。
J Exp Med. 1995 Apr 1;181(4):1527-37. doi: 10.1084/jem.181.4.1527.
5
CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis.CD8+ T 细胞作为人类皮肤利什曼病 IFN-γ 产生的来源。
PLoS Negl Trop Dis. 2010 Oct 12;4(10):e845. doi: 10.1371/journal.pntd.0000845.
6
Immune response to Leishmania antigen in anthroponotic cutaneous leishmaniasis.人源皮肤利什曼病中对利什曼原虫抗原的免疫反应
J Infect. 2009 Aug;59(2):139-43. doi: 10.1016/j.jinf.2009.05.010. Epub 2009 Jun 6.
7
Assessment of intralesional cytokine profile of cutaneous leishmaniasis caused by Leishmania donovani in Sri Lanka.评估斯里兰卡感染利什曼原虫引起的皮肤利什曼病的病灶内细胞因子谱。
BMC Microbiol. 2019 Jan 14;19(1):14. doi: 10.1186/s12866-018-1384-4.
8
Immunologic response and memory T cells in subjects cured of tegumentary leishmaniasis.皮肤利什曼病治愈患者的免疫反应和记忆T细胞。
BMC Infect Dis. 2013 Nov 9;13:529. doi: 10.1186/1471-2334-13-529.
9
Effect of LACK and KMP11 on IFN-gamma production by peripheral blood mononuclear cells from cutaneous and mucosal leishmaniasis patients.LACK和KMP11对皮肤利什曼病和黏膜利什曼病患者外周血单个核细胞产生γ干扰素的影响。
Scand J Immunol. 2005 Apr;61(4):337-42. doi: 10.1111/j.1365-3083.2005.01581.x.
10
CD26 expression on CD4+T cells in patients with cutaneous leishmaniasis.皮肤利什曼病患者CD4+T细胞上CD26的表达
Clin Exp Immunol. 2008 Jul;153(1):31-6. doi: 10.1111/j.1365-2249.2008.03666.x. Epub 2008 May 5.

引用本文的文献

1
Infectiousness of Leishmania major to Phlebotomus papatasi: differences between natural reservoir host Meriones shawi and laboratory model BALB/c mice.硕大利什曼原虫对巴氏白蛉的感染性:自然宿主肖氏子午沙鼠与实验室模型BALB/c小鼠之间的差异。
PLoS Negl Trop Dis. 2025 Jun 16;19(6):e0013183. doi: 10.1371/journal.pntd.0013183. eCollection 2025 Jun.
2
Improving reproducibility and translational potential of mouse models: lessons from studying leishmaniasis.提高小鼠模型的可重复性和转化潜力:利什曼病研究的经验教训。
Front Immunol. 2025 Apr 22;16:1559907. doi: 10.3389/fimmu.2025.1559907. eCollection 2025.
3
Comparative Analysis of Microscopy, Leishmanin Skin Test (LST), and Direct Agglutination Test (DAT) for the Diagnosis of Human Cutaneous Leishmaniasis.

本文引用的文献

1
Cutaneous leishmaniasis: immune responses in protection and pathogenesis.皮肤利什曼病:保护和发病机制中的免疫反应。
Nat Rev Immunol. 2016 Sep;16(9):581-92. doi: 10.1038/nri.2016.72. Epub 2016 Jul 18.
2
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.1990年至2013年188个国家301种急慢性疾病和损伤的全球、区域及国家发病率、患病率和伤残调整生命年:全球疾病负担研究2013的系统分析
Lancet. 2015 Aug 22;386(9995):743-800. doi: 10.1016/S0140-6736(15)60692-4. Epub 2015 Jun 7.
3
用于诊断人类皮肤利什曼病的显微镜检查、利什曼原虫皮肤试验(LST)和直接凝集试验(DAT)的比较分析
Iran J Parasitol. 2025 Jan-Mar;20(1):13-20. doi: 10.18502/ijpa.v20i1.18101.
4
Advances in Vaccines: Current Development and Future Prospects.疫苗进展:当前发展与未来前景
Pathogens. 2024 Sep 20;13(9):812. doi: 10.3390/pathogens13090812.
5
Safety and reactogenicity of a controlled human infection model of sand fly-transmitted cutaneous leishmaniasis.沙蝇传播的皮肤利什曼病人体感染模型的安全性和反应原性。
Nat Med. 2024 Nov;30(11):3150-3162. doi: 10.1038/s41591-024-03146-9. Epub 2024 Aug 2.
6
The level of interleukin-17, 23, and gamma interferon in cutaneous leishmaniasis patients before and after intra lesion treatment.皮肤利什曼病患者病灶内治疗前后白细胞介素-17、23和γ干扰素的水平。
J Parasit Dis. 2022 Jun;46(2):476-482. doi: 10.1007/s12639-021-01428-4. Epub 2022 Feb 3.
7
Potential biomarkers of immune protection in human leishmaniasis.人体利什曼病免疫保护的潜在生物标志物。
Med Microbiol Immunol. 2021 Jun;210(2-3):81-100. doi: 10.1007/s00430-021-00703-8. Epub 2021 May 2.
Therapeutic vaccines for leishmaniasis.
用于利什曼病的治疗性疫苗。
Expert Opin Biol Ther. 2014 Nov;14(11):1641-9. doi: 10.1517/14712598.2014.945415. Epub 2014 Jul 31.
4
Cutaneous leishmaniasis in suspected patients referred to the center for research and training in skin diseases and leprosy, tehran, iran from 2008 to 2011.2008年至2011年转诊至伊朗德黑兰皮肤病与麻风病研究培训中心的疑似皮肤利什曼病患者情况。
Iran J Parasitol. 2013 Jul;8(3):430-6.
5
T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.T 细胞衍生的白细胞介素 10 决定利什曼病的疾病结局,并被基于树突状细胞的疫苗所抑制。
PLoS Pathog. 2013;9(6):e1003476. doi: 10.1371/journal.ppat.1003476. Epub 2013 Jun 27.
6
IL-23 and IL-27 Levels in Macrophages Collected from Peripheral Blood of Patients with Healing Vs Non-Healing Form of Cutaneous Leishmaniasis.从皮肤利什曼病愈合型与非愈合型患者外周血中采集的巨噬细胞中白细胞介素-23和白细胞介素-27水平
Iran J Parasitol. 2012;7(1):18-25.
7
Leishmaniasis worldwide and global estimates of its incidence.全球利什曼病及其发病率的全球估计。
PLoS One. 2012;7(5):e35671. doi: 10.1371/journal.pone.0035671. Epub 2012 May 31.
8
Leishmaniasis in rheumatology, haematology and oncology: epidemiological, immunological and clinical aspects and caveats.风湿学、血液学和肿瘤学中的利什曼病:流行病学、免疫学和临床方面及注意事项。
Ann Rheum Dis. 2012 Apr;71 Suppl 2:i60-6. doi: 10.1136/annrheumdis-2011-200596.
9
Emergence of a new focus of anthroponotic cutaneous leishmaniasis due to Leishmania tropica in rural communities of Bam district after the earthquake, Iran.伊朗 Bam 地区地震后,由于热带利什曼原虫,农村社区中出现了新的人体皮肤利什曼病焦点。
Trop Med Int Health. 2011 Apr;16(4):510-3. doi: 10.1111/j.1365-3156.2011.02729.x. Epub 2011 Jan 24.
10
Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis.皮肤和黏膜利什曼病的当前诊断和治疗。
Expert Rev Anti Infect Ther. 2010 Apr;8(4):419-33. doi: 10.1586/eri.10.19.